Real ‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer
ConclusionsInflammation-related blood data, such as neutrophil count, obtained at the initial pre-treatment visit might serve as potential predictors for prolonged olaparib treatment. While this study offers valuable insights into potential indicators for prolonged olaparib treatment, it underscores the need for more expansive research to strengthen our understanding of PARP inhibitors and optimize treatment strategies in ovarian cancer.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Ryosuke Uekusa,
Akira Yokoi,
Eri Watanabe,
Kosuke Yoshida,
Masato Yoshihara,
Satoshi Tamauchi,
Yusuke Shimizu,
Yoshiki Ikeda,
Nobuhisa Yoshikawa,
Kaoru Niimi,
Shiro Suzuki,
Hiroaki Kajiyama Tags: RESEARCH ARTICLE Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Japan Health | Ovarian Cancer | Ovaries | Serous Carcinoma | Study | Thrombocytopenia